THERAVANCE BIOPHARMA INC
TBPH·G8807B106·US·Common Stock·Healthcare - Biotechnology-Activist
TBPH (THERAVANCE BIOPHARMA INC) is held by 108 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($69.7M), VANGUARD CAPITAL MANAGEMENT LLC ($29M), STATE STREET CORP ($21.1M). Net institutional sentiment: Mixed.
108
Holders
(7 Elite)
$351.8M
Total Value
63% (109)
Consensus
69 buying - 40 selling
13F: Insider & Congress:
Who's Trading
ActivistWAWeiss Asset Management LP14.5%Mar 25, 2026
InsiderFRFarnum RhondaSell $108KMar 16, 2026
InsiderFRFarnum RhondaSell $217KMar 16, 2026
InsiderFRFarnum RhondaSell $108KMar 16, 2026
ActivistNENewtyn Management, LLC8.5%Feb 17, 2026
InsiderFRFarnum RhondaSell $146KDec 3, 2025
InsiderFRFarnum RhondaSell $146KDec 3, 2025
InsiderFRFarnum RhondaSell $291KDec 3, 2025
InsiderBEBROSHY ERANSell $280KNov 26, 2025
Top Holders
Showing 1-20 of 119
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer